Biktarvy, formally known as bictegravir, is a powerful single-tablet therapy for controlling HIV infection. This formula combines three crucial antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It works by preventing the HIV's ability to replicate within the body, considerably lowering the viral burden. For many individ